| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation of systemic and mucosal immune response following nasal administration of liposomes
|
Aramaki, Yukihiko
|
|
1994
|
12 |
13 |
p. 1241-1245
5 p.
|
article
|
| 2 |
A framework for the evaluation of vaccines for use in the expanded programme on immunization
|
Aylward, Bruce
|
|
1994
|
12 |
13 |
p. 1155-1159
5 p.
|
article
|
| 3 |
Barriers to immunization — an examination of factors that influence the application of pneumococcal vaccine by house staff
|
Rushton, Thomas C.
|
|
1994
|
12 |
13 |
p. 1173-1179
7 p.
|
article
|
| 4 |
Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys
|
von Gegerfelt, Agneta
|
|
1994
|
12 |
13 |
p. 1203-1208
6 p.
|
article
|
| 5 |
Calendar
|
|
|
1994
|
12 |
13 |
p. 1247-
1 p.
|
article
|
| 6 |
Demonstration of a virulent subpopulation in a prototype live attenuated turkey rhinotracheitis vaccine
|
Naylor, C.J.
|
|
1994
|
12 |
13 |
p. 1225-1230
6 p.
|
article
|
| 7 |
Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells
|
Rouaix, F.
|
|
1994
|
12 |
13 |
p. 1209-1214
6 p.
|
article
|
| 8 |
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin
|
Tamura, Shin-ichi
|
|
1994
|
12 |
13 |
p. 1238-1240
3 p.
|
article
|
| 9 |
Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules
|
Lees, Andrew
|
|
1994
|
12 |
13 |
p. 1160-1166
7 p.
|
article
|
| 10 |
Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants
|
Ganne, V.
|
|
1994
|
12 |
13 |
p. 1190-1196
7 p.
|
article
|
| 11 |
Flavivirus live recombinant vaccine; surface antigen and protease expression
|
|
|
1994
|
12 |
13 |
p. 1246-
1 p.
|
article
|
| 12 |
Hantaan virus nucleocapsid N protein or G1, G2 glycoprotein precursor cDNA DNA sequence; vector e.g. plasmid pGEM1, plasmid pBR322 or phage M13, expression in e.g. Escherichia coli; application as a recombinant vaccine
|
|
|
1994
|
12 |
13 |
p. 1246-
1 p.
|
article
|
| 13 |
Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
|
Govaert, Th.M.E.
|
|
1994
|
12 |
13 |
p. 1185-1189
5 p.
|
article
|
| 14 |
Immunization of cottontop tamarins and rabbits with a candidate vaccine against the Epstein-Barr virus based on the major viral envelope glycoprotein gp340 and alum
|
Finerty, S.
|
|
1994
|
12 |
13 |
p. 1180-1184
5 p.
|
article
|
| 15 |
Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1; tumour rejection antigen precursor production; expression in mouse or CHO cell culture, and application as a recombinant vaccine; monoclonal antibody
|
|
|
1994
|
12 |
13 |
p. 1246-
1 p.
|
article
|
| 16 |
Measles seroprevalence and vaccine response in HIV-infected adults
|
Wallace, Mark R.
|
|
1994
|
12 |
13 |
p. 1222-1224
3 p.
|
article
|
| 17 |
Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom
|
|
|
1994
|
12 |
13 |
p. 1248-
1 p.
|
article
|
| 18 |
New immunocomplex of lymphoma tumour-associated antigen and cytokine; recombinant vaccine against B-lymphocyte lymphoma
|
|
|
1994
|
12 |
13 |
p. 1246-
1 p.
|
article
|
| 19 |
Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids
|
Mirchamsy, Hossein
|
|
1994
|
12 |
13 |
p. 1167-1172
6 p.
|
article
|
| 20 |
Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development
|
Eko, Francis O.
|
|
1994
|
12 |
13 |
p. 1231-1237
7 p.
|
article
|
| 21 |
Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin
|
Toth, Andor
|
|
1994
|
12 |
13 |
p. 1215-1221
7 p.
|
article
|
| 22 |
The cell-binding carboxyterminal undecapeptide of SV40 tumour antigen provides protective cell-dependent immunity
|
Hanagarth, Hans-Günter
|
|
1994
|
12 |
13 |
p. 1197-1202
6 p.
|
article
|
| 23 |
Thiol protease with cathepsin L-type activity; recombinant cathepsin-L1 and -L2 production; DNA sequence; monoclonal antibody; potential Fasciola hepatica recombinant vaccine
|
|
|
1994
|
12 |
13 |
p. 1246-
1 p.
|
article
|
Journal description